PMID- 35777582 OWN - NLM STAT- MEDLINE DCOM- 20220726 LR - 20220728 IS - 1879-0631 (Electronic) IS - 0024-3205 (Linking) VI - 305 DP - 2022 Sep 15 TI - Urine protein in patients with type I hypersensitivity is indicative of reversible renal tube injury. PG - 120735 LID - S0024-3205(22)00435-0 [pii] LID - 10.1016/j.lfs.2022.120735 [doi] AB - AIMS: In our clinical work, some patients with type I hypersensitivity could be detected protein in their urine. This study focused on the early renal injury in patients with type I hypersensitivity. MAIN METHODS: From 43 type I hypersensitivity patients with proteinuria, 10 patients were randomly selected for mass spectrometry analysis of 24-h urine together with 5 healthy volunteers. Mice were vaccinated with Dermatophagoides farina (Der f) and ovalbumin (OVA) were used as antigen to establish the type I hypersensitivity animal models. KEY FINDINGS: The urine protein of hypersensitivity patients was significantly increased in the alpha-1-microglobulin/ bikunin precursor (Protein AMBP) (t = 3.140, P = 0.008), retinol binding protein 4 (RBP4) (t = 2.426, P = 0.031), kininogen-1 (t = 2.501, P = 0.027), and transferrin appeared only in patients' urine. After immunizing mice with antigens, significant increases of the total serum immunoglobulin E (IgE) were observed in both Der f (86.92 +/- 36.01 U/mL, t = 5.231, P = 0.0004) and OVA group (34.65 +/- 24.72 U/mL, t = 2.891, P = 0.0161) compared with the negative control group (2.68 +/- 0.47 U/mL). Meanwhile, definite eosinophil infiltration around the impaired renal tubules as well as the bronchus in Der f mice were observed, and urine protein appeared. After stopping the allergen stimulation, proteinuria disappeared. Instead, when the mice were treated with the antigen again, proteinuria reappeared. SIGNIFICANCE: Our findings suggest that renal tubular damage in patients with type I hypersensitivity is reversible, and proteinuria disappears with allergy symptoms remission. CI - Copyright (c) 2022 Elsevier Inc. All rights reserved. FAU - Cao, Yong AU - Cao Y AD - School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. FAU - Shao, Li AU - Shao L AD - Department of Allergy, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Xin, Mei AU - Xin M AD - Department of Nuclear Medicine, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Zhang, Yilun AU - Zhang Y AD - School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. FAU - Xu, Yanhua AU - Xu Y AD - Department of Allergy, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Song, Yang AU - Song Y AD - Department of Allergy, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Lu, Hui AU - Lu H AD - Department of Allergy, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Wang, Yiwei AU - Wang Y AD - Department of Allergy, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Xia, Ying AU - Xia Y AD - Department of Allergy, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Zhang, Meixing AU - Zhang M AD - School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. FAU - Guo, Yinshi AU - Guo Y AD - Department of Allergy, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Wang, Lianyun AU - Wang L AD - School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China; Department of Allergy, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. FAU - Qiao, Zhongdong AU - Qiao Z AD - School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. Electronic address: zdqiao@sjtu.edu.cn. LA - eng PT - Journal Article DEP - 20220628 PL - Netherlands TA - Life Sci JT - Life sciences JID - 0375521 RN - 0 (Allergens) RN - 0 (RBP4 protein, human) RN - 0 (Retinol-Binding Proteins, Plasma) RN - 37341-29-0 (Immunoglobulin E) RN - 9006-59-1 (Ovalbumin) SB - IM MH - Allergens MH - Animals MH - Humans MH - *Hypersensitivity/complications MH - Hypersensitivity, Immediate MH - Immunoglobulin E MH - *Kidney MH - Mice MH - Ovalbumin MH - *Proteinuria MH - Retinol-Binding Proteins, Plasma OTO - NOTNLM OT - Proteinuria OT - Renal damage OT - Type I hypersensitivity EDAT- 2022/07/02 06:00 MHDA- 2022/07/27 06:00 CRDT- 2022/07/01 19:25 PHST- 2021/12/05 00:00 [received] PHST- 2022/04/07 00:00 [revised] PHST- 2022/06/23 00:00 [accepted] PHST- 2022/07/02 06:00 [pubmed] PHST- 2022/07/27 06:00 [medline] PHST- 2022/07/01 19:25 [entrez] AID - S0024-3205(22)00435-0 [pii] AID - 10.1016/j.lfs.2022.120735 [doi] PST - ppublish SO - Life Sci. 2022 Sep 15;305:120735. doi: 10.1016/j.lfs.2022.120735. Epub 2022 Jun 28.